If it’s developed like a drug, has endpoints like a drug’s, and is prescribed like a drug, it might be a drug. Or, lately, it might also be a smartphone application. The first prescription apps are about to arrive on the market, and major pharmaceutical companies are buying in.

Click Therapeutics, based in New York, announced Monday that Sanofi (SNY) Ventures would be providing $17 million in funding, in exchange for equity in the company and a seat on its board. In April, Pear Therapeutics and Sandoz, a division of Novartis (NVS), established a partnership to commercialize their prescription app for substance abuse, which received FDA clearance in September after going through the agency’s digital health pre-certification program. And Akili Interactive closed a $55 million Series C funding round that included Merck’s (MRK) corporate venture capital fund in May.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • To date I have never allowed anything that is about my personal health care, to be online for anyone or anything. My former physician has a specialized device that he uses for his patient notes, hospital discharges; and when ordering prescriptions for his patients. I wish all the physicians were required to use such a device. My pharmacy is never allowed to have my prescriptions online either.

    The activist who is part of myself is prepared to try everything imaginable, to insure that my private health remains just that – private!

    This app hopefully will never be used for anything by anyone.

  • What happens to those seniors who do not have electronic capability? Will they end up in the dark with no medication, or will they be able to continue with the traditional methods of medication access?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy